NCT03402009

Brief Summary

The purpose of this study is to determine what tools best assist university students develop a personal meditation practice to self-manage stress. The two treatment conditions are 1) independent meditation using web-based tools and apps, and 2) independent meditation using web-based tools, apps and EEG-based neurofeedback. Outcomes of interest include acceptability, adherence, changes in mental health (i.e., anxiety, stress), physical health (i.e., sleep, inflammation), resilience, and level of commitment to further practice. Factors related to self-regulation (i.e., interoceptive awareness, self-esteem) will also be assessed as potential outcome moderators.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

March 5, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

September 26, 2019

Status Verified

September 1, 2019

Enrollment Period

9 months

First QC Date

December 6, 2017

Last Update Submit

September 25, 2019

Conditions

Keywords

meditationMindfulnessstressanxiety

Outcome Measures

Primary Outcomes (1)

  • Change in Depression, Anxiety, and Stress Scales-21

    (DASS-21; Lovibond \& Lovibond, 1995): an abbreviated, 21-item, Likert-style scale to assess levels of distress on three subscales: depression, anxiety and stress, based on how one felt over the past week. The DASS-21 has been used in prior studies assessing the benefits of mindfulness in undergraduate students (Gallego et al., 2014). It consists of 21 items with seven items per subscale, scored on a four-point scale ranging from 0 = did not apply to me at all to 3 = applied to me very much or most of the time. The total score sums all items. Higher scores indicate higher levels of distress.

    5 weeks

Secondary Outcomes (12)

  • Big Five personality

    Baseline and 5 weeks

  • Pittsburgh Sleep Quality Index

    Baseline and 5 weeks

  • Self-Regulation of Eating Scale

    Baseline and 5 weeks

  • MINDSENS (mindfulness)

    Baseline and 5 weeks

  • Multidimensional Assessment of Interoceptive Awareness (MAIA)

    Baseline and 5 weeks

  • +7 more secondary outcomes

Other Outcomes (2)

  • Long-term Follow-up Survey

    1, 6, and 12 months following completion of the satisfaction follow-up

  • Satisfaction with Mindfulness Tools

    5 weeks

Study Arms (2)

Experimental

EXPERIMENTAL

independent meditation using web-based tools, apps, and EEG neurofeedback

Behavioral: AppsBehavioral: EEG neurofeedback

Active Control

ACTIVE COMPARATOR

independent meditation using web-based tools and apps

Behavioral: Apps

Interventions

AppsBEHAVIORAL

Apps and weblinks to coach self-guided meditation.

Active ControlExperimental

Device provides feedback based on EEG readings.

Experimental

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • English literate, undergraduates and graduate students attending UConn ages 18 and above (unless they are registered with the participant pool), who agree with the initial terms, are willing to learn basic skills of mindfulness meditation, agree to practice meditating with assigned tools independently and feel able to adhere to the time commitment required for the study. Participants must not currently have a regular seated meditation practice (regular, meaning at least 1x per week).

You may not qualify if:

  • participants unable to adhere to the commitment required for the study will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Connecticut

Storrs, Connecticut, 06269, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Amyloid Precursor Protein Secretases

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

EndopeptidasesPeptide HydrolasesHydrolasesEnzymesEnzymes and Coenzymes

Study Officials

  • Blair T. Johnson, PhD

    University of Connecticut - BOT Distinguished Professor of Psychological Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
BoT Distinguished Professor of Psychological Sciences

Study Record Dates

First Submitted

December 6, 2017

First Posted

January 17, 2018

Study Start

March 5, 2018

Primary Completion

December 5, 2018

Study Completion

December 31, 2019

Last Updated

September 26, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for primary and secondary outcome measures will be made available upon request.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available after results have been published.
Access Criteria
Data access requests will be reviewed and requestors will be required to sign a Data Access Agreement

Locations